Author response: ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation

Qi Zeng(Southwest Jiaotong University), Shuai Chen(Fujian Medical University)
Unknown
October 7, 2024
Cited by 0


Related Papers